What 8 Analyst Ratings Have To Say About Medtronic
Portfolio Pulse from Benzinga Insights
Medtronic (NYSE:MDT) received mixed analyst ratings over the last quarter, with a range of price targets and evaluations. The average 12-month price target is $88.25, slightly down from the previous $89.86. Analysts' actions include both downgrades and upgrades, reflecting varied sentiments about the company's future performance.
July 16, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Medtronic received mixed ratings from analysts, with an average 12-month price target of $88.25, down from $89.86. Analysts' actions include downgrades from Truist Securities and Citigroup, and upgrades from Wells Fargo and UBS.
The mixed ratings and slight decrease in the average price target suggest a neutral short-term impact on Medtronic's stock price. The varied analyst actions indicate uncertainty about the company's near-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100